Erythema Toxicum Neonatorum in Newborns and the Development of Asthma

The Implication of Erythema Toxicum Neonatorum in Newborns on the Development of Future Asthma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00178152

Enrollment

334

Registered

2005-09-15

Start date

2005-05-31

Completion date

2005-11-30

Last updated

2011-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Erythema Toxicum Neonatorum

Brief summary

Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of research addressing this issue.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

3 Years to 9 Years

Healthy volunteers

Inclusion criteria

* Children between the ages of 3-9 years who have had at least 2 asthma diagnoses within the last 2 years. * Control subjects will be age matched and without an asthma diagnosis.

Exclusion criteria

* Children without accessible medical records

Countries

United States

Outcome results